Current recommendations and emerging options for the treatment of allergic rhinitis

Amelia Licari; Giorgio Ciprandi; Alessia Marseglia; Riccardo Castagnoli; Salvatore Barberi; Silvia Caimmi; Gian Luigi Marseglia

doi:10.1586/1744666X.2014.955476

Current recommendations and emerging options for the treatment of allergic rhinitis

Amelia Licari, Giorgio Ciprandi, Alessia Marseglia, Riccardo Castagnoli, Salvatore Barberi, Silvia Caimmi, Gian Luigi Marseglia

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

Original language	English
Pages (from-to)	1337-1347
Number of pages	11
Journal	Expert Review of Clinical Immunology
Volume	10
Issue number	10
DOIs	https://doi.org/10.1586/1744666X.2014.955476
Publication status	Published - Oct 1 2014

Keywords

allergic rhinitis
drugs
efficacy
immunology
inflammation
safety
therapy

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1586/1744666X.2014.955476

Fingerprint Dive into the research topics of 'Current recommendations and emerging options for the treatment of allergic rhinitis'. Together they form a unique fingerprint.

Cite this

Current recommendations and emerging options for the treatment of allergic rhinitis. / Licari, Amelia; Ciprandi, Giorgio; Marseglia, Alessia; Castagnoli, Riccardo; Barberi, Salvatore; Caimmi, Silvia ; Marseglia, Gian Luigi.

In: Expert Review of Clinical Immunology, Vol. 10, No. 10, 01.10.2014, p. 1337-1347.

Research output: Contribution to journal › Article › peer-review

@article{26cdf76278454f4eb362f9c5adbe3ff5,

title = "Current recommendations and emerging options for the treatment of allergic rhinitis",

abstract = "Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.",

keywords = "allergic rhinitis, drugs, efficacy, immunology, inflammation, safety, therapy",

author = "Amelia Licari and Giorgio Ciprandi and Alessia Marseglia and Riccardo Castagnoli and Salvatore Barberi and Silvia Caimmi and Marseglia, {Gian Luigi}",

year = "2014",

month = oct,

day = "1",

doi = "10.1586/1744666X.2014.955476",

language = "English",

volume = "10",

pages = "1337--1347",

journal = "Expert Review of Clinical Immunology",

issn = "1744-666X",

publisher = "Expert Reviews Ltd.",

number = "10",

}

TY - JOUR

T1 - Current recommendations and emerging options for the treatment of allergic rhinitis

AU - Licari, Amelia

AU - Ciprandi, Giorgio

AU - Marseglia, Alessia

AU - Castagnoli, Riccardo

AU - Barberi, Salvatore

AU - Caimmi, Silvia

AU - Marseglia, Gian Luigi

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

AB - Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

KW - allergic rhinitis

KW - drugs

KW - efficacy

KW - immunology

KW - inflammation

KW - safety

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=84907278919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907278919&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2014.955476

DO - 10.1586/1744666X.2014.955476

M3 - Article

C2 - 25225773

AN - SCOPUS:84907278919

VL - 10

SP - 1337

EP - 1347

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 10

ER -